norethindrone and elagolix

norethindrone has been researched along with elagolix in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's4 (100.00)2.80

Authors

AuthorsStudies
Al-Hendy, A; Archer, DF; Barnhart, KT; Bradley, LD; Carr, BR; Dayspring, T; Feinberg, EC; Gillispie, V; Hurtado, S; Kim, J; Liu, R; Muneyyirci-Delale, O; Owens, CD; Schlaff, WD; Simon, JA; Wang, A; Watts, NB1
A R, S; Al Hendy, A; Ali, M1
Chiu, YL; Feldman, RA; Klein, CE; Ng, J1
Antoun, J1

Reviews

2 review(s) available for norethindrone and elagolix

ArticleYear
Elagolix in the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
    Expert review of clinical pharmacology, 2021, Volume: 14, Issue:4

    Topics: Animals; Drug Combinations; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Hydrocarbons, Fluorinated; Leiomyoma; Menorrhagia; Norethindrone; Premenopause; Pyrimidines; Uterine Neoplasms

2021
Elagolix, Estradiol, and Norethindrone Kit (Oriahnn) for the Management of Heavy Menstrual Bleeding Associated with Fibroids.
    American family physician, 2021, 04-15, Volume: 103, Issue:8

    Topics: Adult; Contraceptives, Oral, Hormonal; Disease Management; Estradiol; Estrogens; Female; Humans; Hydrocarbons, Fluorinated; Leiomyoma; Menorrhagia; Norethindrone; Pyrimidines; Uterine Neoplasms

2021

Trials

1 trial(s) available for norethindrone and elagolix

ArticleYear
Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas.
    Obstetrics and gynecology, 2020, Volume: 135, Issue:6

    Topics: Adult; Bone Density; Double-Blind Method; Drug Therapy, Combination; Estradiol; Female; Gonadotropin-Releasing Hormone; Headache; Hot Flashes; Humans; Hydrocarbons, Fluorinated; Leiomyoma; Menorrhagia; Middle Aged; Nausea; Norethindrone; Pyrimidines; Quality of Life; Uterine Neoplasms

2020

Other Studies

1 other study(ies) available for norethindrone and elagolix

ArticleYear
Pharmacokinetic and Pharmacodynamic Profiles of Ethinylestradiol/Norgestimate Combination or Norethindrone upon Coadministration with Elagolix 150 mg Once Daily in Healthy Premenopausal Women.
    Clinical pharmacokinetics, 2021, Volume: 60, Issue:8

    Topics: Female; Follicle Stimulating Hormone; Humans; Hydrocarbons, Fluorinated; Luteinizing Hormone; Norethindrone; Norgestrel; Pyrimidines

2021